Patents Assigned to Serodus AS
  • 5-HT4 receptor antagonists for the treatment of heart failure
    Patent number: 8829028
    Abstract: This invention provides the use of a 5-HT4 receptor antagonist in the manufacture of a medicament for treating or preventing heart failure. Particular heart disorders to be treated are selected from the group comprising chronic heart failure, congestive heart failure, chronic congestive heart failure and heart failure resulting from ischaemic heart disease. Methods of treating heart failure using 5-HT4 receptor antagonists and pharmaceutical compositions containing 5-HT4 receptor antagonists are also provided.
    Type: Grant
    Filed: February 17, 2009
    Date of Patent: September 9, 2014
    Assignee: Serodus AS
    Inventor: Finn Olav Levy
  • Modulators of peripheral 5-HT receptors
    Patent number: 7834010
    Abstract: The invention relates to modulators of peripheral 5-HT receptors, particularly 5-HT4 receptors, said modulators essentially selective for peripheral 5-HT receptors over receptors of the central nervous system. The invention allows for the treatment, amongst others, of gastrointestinal disorders, lower urinary tract disorders, and cardiovascular disorders without side effects related to CNS activity.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: November 16, 2010
    Assignee: Serodus AS
    Inventors: Jo Klaveness, Finn Olav Levy, Bjarne Brudeli